Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Superconductivity of topological insulator Sb2Te3-ySeyunder pressure.
Taguchi T, Ikeda M, Li H, Suzuki A, Yang X, Ishii H, Liao YF, Ota H, Goto H, Eguchi R, Kubozono Y. Taguchi T, et al. Among authors: ikeda m. J Phys Condens Matter. 2021 Sep 22;33(48). doi: 10.1088/1361-648X/ac244b. J Phys Condens Matter. 2021. PMID: 34492649
Superconducting properties of BaBi3 at ambient and high pressures.
Wang Y, Taguchi T, Li H, Suzuki A, Zhang Y, Miura A, Ikeda M, Goto H, Eguchi R, Miyazaki T, Liao YF, Ishii H, Kubozono Y. Wang Y, et al. Among authors: ikeda m. Phys Chem Chem Phys. 2021 Oct 20;23(40):23014-23023. doi: 10.1039/d1cp00042j. Phys Chem Chem Phys. 2021. PMID: 34612269
Superconducting Behavior of BaTi2(Sb1-yBiy)2O under Pressure.
Ikeda M, Suzuki A, Zhang Y, Goto H, Eguchi R, Liao YF, Ishii H, Kubozono Y. Ikeda M, et al. Inorg Chem. 2022 Dec 19;61(50):20538-20546. doi: 10.1021/acs.inorgchem.2c03365. Epub 2022 Dec 8. Inorg Chem. 2022. PMID: 36480275
Superstructure of Fe5-xGeTe2 Determined by Te K-Edge Extended X-ray Absorption Fine Structure and Te Kα X-ray Fluorescence Holography.
Eguchi R, Sekhar H, Kimura K, Masai H, Happo N, Ikeda M, Yamamoto Y, Utsumi M, Goto H, Takabayashi Y, Tajiri H, Hayashi K, Kubozono Y. Eguchi R, et al. Among authors: ikeda m. ACS Omega. 2024 May 1;9(19):21287-21297. doi: 10.1021/acsomega.4c01395. eCollection 2024 May 14. ACS Omega. 2024. PMID: 38764676 Free PMC article.
Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22.
Imaoka H, Sasaki K, Machida R, Nagano H, Satoi S, Ikeda M, Kobayashi S, Yamashita T, Okusaka T, Ido A, Hatano E, Miwa H, Ueno M, Nakao K, Shimizu S, Kuramochi H, Sakamori R, Tsumura H, Okano N, Shioji K, Shirakawa H, Akutsu N, Tsuji K, Ishii H, Umemoto K, Asagi A, Ueno M; JCOG Hepatobiliary and Pancreatic Oncology Group. Imaoka H, et al. Among authors: ikeda m. Jpn J Clin Oncol. 2024 Jun 7:hyae048. doi: 10.1093/jjco/hyae048. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 38843879
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).
Kobayashi K, Ogasawara S, Itobayashi E, Okubo T, Itokawa N, Nakamura K, Moriguchi M, Watanabe S, Ikeda M, Kuroda H, Kawaoka T, Hiraoka A, Yasui Y, Kuzuya T, Sato R, Kanzaki H, Koroki K, Inoue M, Nakamura M, Kiyono S, Kanogawa N, Kondo T, Nakamoto S, Ozawa Y, Tsuchiya K, Atsukawa M, Aikata H, Aramaki T, Oka S, Morimoto N, Kurosaki M, Itoh Y, Izumi N, Kato N. Kobayashi K, et al. Among authors: ikeda m. Invest New Drugs. 2024 Jun 6. doi: 10.1007/s10637-024-01441-3. Online ahead of print. Invest New Drugs. 2024. PMID: 38842657
6,536 results